Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Linnaeus Plant Sciences is a Canadian agricultural biotechnology company specializing in the development of Camelina sativa as a high-value industrial and nutritional oilseed crop. Based in Saskatoon, Saskatchewan, the company utilizes advanced plant breeding and genetic engineering to create superior Camelina varieties with optimized fatty acid profiles and enhanced agronomic traits such as herbicide resistance. Through its commercial affiliate, Smart Earth Seeds, the company markets elite cultivars such as MIDAS and SES1154HR, as well as finished products like cold-pressed Camelina oil for equine and canine health. Linnaeus operates an integrated biorefinery model, providing sustainable, biodegradable alternatives to petroleum-based feedstocks for sectors including lubricants, polymers, and aquaculture. The company maintains strategic partnerships with global organizations like Corteva and the University of Saskatchewan to advance its proprietary plant-based technology platform.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Linnaeus Plant Sciences.